Fallopian Tube Cancer
Fallopian tube cancer is a rare type of cancer that begins in the fallopian tubes, which connect the ovaries to the uterus. Symptoms may include abdominal pain, unusual vaginal bleeding, and pelvic discomfort.
Ovarian Cancer: PARP Inhibitor with Cisplatin and Heat Therapy
We are studying a new treatment approach for ovarian cancer that combines a PARP inhibitor with cisplatin and heat during surgery. This trial aims to see if this combination improves outcomes for patients.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Ovarian Cancer
Ovarian cancer originates in the ovaries and can cause symptoms such as abdominal swelling, pain, and changes in appetite. Early detection is crucial for effective treatment.
Extraovarian Cancer
Extraovarian cancer refers to cancer that occurs outside the ovaries but may still affect the reproductive system. Symptoms can vary widely depending on the location and extent of the disease.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Gynaecologic Oncology
Amstelveen, Netherlands
Sponsor: Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.